
Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy
Keywords: HBV; hepatitis B virus; CHB; chronic hepatitis B; HCC; hepatocellular carcinoma; HBeAg; hepatitis B e antigen; Ab; antibody; anti-HBe; antibodies against HBeAg; PEG-IFN-α; pegylated interferon alpha; Tfh; follicular T helper cells; CXCR5; chemokine (C-X-